MarketPeel
MP

Michael B. Jr. Petras

SHC
CHAIRMAN & CEO · SOTERA HEALTH CO · CIK 0001832387
FILING MIX · LIFETIME37%/63%
BUYS
15
SELLS
26
TOTAL VALUE
$106.17M
COMPANIES
1
ACTIVE SINCE
Nov 2020
HOLDINGS NOW
397,912
AVG SELL PX
$19.04
TRADE KIND
SHOWING 41 / 41
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizons · 6 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Michael B. Jr. Petras, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+40.00%-1.47%-0.13%-1.34%+1.63%
14d5+40.00%+1.88%+0.89%+0.99%+3.92%
30d5+40.00%+3.36%+2.06%+1.30%+12.38%
60d5+40.00%-2.29%+1.77%-4.07%+5.91%
90d5+100.00%-13.51%+1.71%-15.22%-11.45%
180d5+50.00%+1.79%+9.50%-10.15%-10.15%
1y5(3 pending)+100.00%-18.73%+15.04%-33.77%-33.77%
2y5(3 pending)+50.00%-11.66%+19.39%-31.04%-31.04%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
SHC · 397,912 shares · as of Aug 17, 2026
01,798,6563,597,3125,395,9687,194,624202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
2026
FLOW · 15 buys / 26 sellsCOVERAGE · 24 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
SHC
SOTERA HEALTH CO
SALE
Executive Chairman
294,515$18.50$5.45M397,912Aug 17, 2026Aug 19, 2026View →
SHC
SOTERA HEALTH CO
SALE
Executive Chairman
850,000$18.50$15.73M3,969,393Aug 17, 2026Aug 19, 2026View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
120,124120,124Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
PURCHASE
Chairman & CEO
89,686570,835Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
89,68659,790Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
240,248692,427Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
40,302$15.91$641.2K481,149Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
79,104$15.91$1.26M452,179Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
39,552$15.91$629.3K531,283Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
31,339$15.91$498.6K521,451Mar 2, 2026Mar 4, 2026View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
315,896$16.45$5.20M552,790Dec 8, 2025Dec 10, 2025View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
394,861$16.45$6.50M4,819,393Dec 8, 2025Dec 10, 2025View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
39,243$16.45$645.5K0Dec 8, 2025Dec 10, 2025View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
298,953868,603Mar 3, 2025Mar 4, 2025View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
149,476149,476Mar 3, 2025Mar 4, 2025View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
40,987$12.47$511.1K569,650Mar 2, 2025Mar 4, 2025View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
27,990$12.47$349.0K642,509Mar 2, 2025Mar 4, 2025View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
31,872$12.47$397.4K610,637Mar 2, 2025Mar 4, 2025View →
SHC
SOTERA HEALTH CO
SALEGRANT
Gift
39,2435,214,337Nov 22, 2024Nov 22, 2024View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Gift
39,24339,243Nov 22, 2024Nov 22, 2024View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
29,250$13.21$386.4K670,499Nov 20, 2024Nov 22, 2024View →
SHC
SOTERA HEALTH CO
SALEGRANT
Gift
200,0005,253,580Sep 10, 2024Sep 12, 2024View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
544,509544,509Mar 4, 2024Mar 5, 2024View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
274,160699,749Mar 4, 2024Mar 5, 2024View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
1,003,870$14.31$14.36M5,453,580Mar 4, 2024Mar 5, 2024View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
21,574$14.56$314.1K425,589Mar 2, 2024Mar 5, 2024View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
27,990$14.56$407.5K447,163Mar 2, 2024Mar 5, 2024View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
29,250$13.93$407.5K555,418Nov 20, 2023Nov 22, 2023View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
213,189584,668Mar 6, 2023Mar 8, 2023View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
404,094404,094Mar 6, 2023Mar 8, 2023View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
19,841$17.41$345.4K371,479Mar 2, 2023Mar 6, 2023View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
29,251$6.02$176.1K391,320Nov 20, 2022Nov 22, 2022View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
2,108,3562,108,356Nov 7, 2022Nov 9, 2022View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
478,932478,932Mar 2, 2022Mar 4, 2022View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
187,219420,571Mar 2, 2022Mar 4, 2022View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
27,517$22.54$620.2K233,352Nov 20, 2021Nov 23, 2021View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
817,439$26.12$21.35M6,377,185Mar 22, 2021Mar 24, 2021View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
946,102$21.68$20.51M7,194,624Nov 24, 2020Nov 24, 2020View →
SHC
SOTERA HEALTH CO
SALE
Chairman & CEO
437,821$21.68$9.49M0Nov 24, 2020Nov 24, 2020View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
260,869260,869Nov 20, 2020Nov 24, 2020View →
SHC
SOTERA HEALTH CO
PURCHASEGRANT
Stock grant
1,118,0121,118,012Nov 20, 2020Nov 24, 2020View →
Other insiders · SHC
Loading peer insiders…
About this filer
CIK 0001832387
ROLE
Chairman & CEO
PRIMARY
SHC
COMPANIES
1
ACTIVE SINCE
Nov 2020
MARKETPEEL · /INSIDER/0001832387DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback